nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Alkylating Activity—Ifosfamide—germ cell cancer	0.516	1	CiPCiCtD
Temozolomide—malignant glioma—germ cell cancer	0.187	0.443	CtDrD
Temozolomide—brain cancer—germ cell cancer	0.0939	0.223	CtDrD
Temozolomide—melanoma—germ cell cancer	0.073	0.173	CtDrD
Temozolomide—skin cancer—germ cell cancer	0.0679	0.161	CtDrD
Temozolomide—CYP3A4—Ifosfamide—germ cell cancer	0.00654	0.498	CbGbCtD
Temozolomide—CYP3A4—Vinblastine—germ cell cancer	0.00347	0.264	CbGbCtD
Temozolomide—CYP3A4—Etoposide—germ cell cancer	0.00313	0.238	CbGbCtD
Temozolomide—Alopecia—Cisplatin—germ cell cancer	6.18e-05	0.00126	CcSEcCtD
Temozolomide—Hepatic failure—Methotrexate—germ cell cancer	6.17e-05	0.00126	CcSEcCtD
Temozolomide—Cough—Ifosfamide—germ cell cancer	6.16e-05	0.00125	CcSEcCtD
Temozolomide—Thrombocytopenia—Dactinomycin—germ cell cancer	6.16e-05	0.00125	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	6.14e-05	0.00125	CcSEcCtD
Temozolomide—Convulsion—Ifosfamide—germ cell cancer	6.12e-05	0.00124	CcSEcCtD
Temozolomide—Hypertension—Ifosfamide—germ cell cancer	6.09e-05	0.00124	CcSEcCtD
Temozolomide—Erythema—Cisplatin—germ cell cancer	6.09e-05	0.00124	CcSEcCtD
Temozolomide—Malnutrition—Cisplatin—germ cell cancer	6.09e-05	0.00124	CcSEcCtD
Temozolomide—Erythema multiforme—Etoposide—germ cell cancer	6.06e-05	0.00123	CcSEcCtD
Temozolomide—Paraesthesia—Bleomycin—germ cell cancer	6.05e-05	0.00123	CcSEcCtD
Temozolomide—Dyspnoea—Bleomycin—germ cell cancer	6.01e-05	0.00122	CcSEcCtD
Temozolomide—Arthralgia—Ifosfamide—germ cell cancer	6.01e-05	0.00122	CcSEcCtD
Temozolomide—Myalgia—Ifosfamide—germ cell cancer	6.01e-05	0.00122	CcSEcCtD
Temozolomide—Anorexia—Dactinomycin—germ cell cancer	5.99e-05	0.00122	CcSEcCtD
Temozolomide—Eye disorder—Etoposide—germ cell cancer	5.99e-05	0.00122	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	5.97e-05	0.00121	CcSEcCtD
Temozolomide—Cardiac disorder—Etoposide—germ cell cancer	5.94e-05	0.00121	CcSEcCtD
Temozolomide—Flushing—Etoposide—germ cell cancer	5.94e-05	0.00121	CcSEcCtD
Temozolomide—Discomfort—Ifosfamide—germ cell cancer	5.94e-05	0.00121	CcSEcCtD
Temozolomide—Hypersensitivity—Vinblastine—germ cell cancer	5.88e-05	0.0012	CcSEcCtD
Temozolomide—Dermatitis exfoliative—Methotrexate—germ cell cancer	5.88e-05	0.0012	CcSEcCtD
Temozolomide—Decreased appetite—Bleomycin—germ cell cancer	5.86e-05	0.00119	CcSEcCtD
Temozolomide—Angiopathy—Etoposide—germ cell cancer	5.81e-05	0.00118	CcSEcCtD
Temozolomide—Confusional state—Ifosfamide—germ cell cancer	5.81e-05	0.00118	CcSEcCtD
Temozolomide—Immune system disorder—Etoposide—germ cell cancer	5.78e-05	0.00118	CcSEcCtD
Temozolomide—Mediastinal disorder—Etoposide—germ cell cancer	5.77e-05	0.00117	CcSEcCtD
Temozolomide—Pain—Bleomycin—germ cell cancer	5.76e-05	0.00117	CcSEcCtD
Temozolomide—Oedema—Ifosfamide—germ cell cancer	5.76e-05	0.00117	CcSEcCtD
Temozolomide—Anaphylactic shock—Ifosfamide—germ cell cancer	5.76e-05	0.00117	CcSEcCtD
Temozolomide—Chills—Etoposide—germ cell cancer	5.75e-05	0.00117	CcSEcCtD
Temozolomide—Vision blurred—Cisplatin—germ cell cancer	5.74e-05	0.00117	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	5.73e-05	0.00117	CcSEcCtD
Temozolomide—Asthenia—Vinblastine—germ cell cancer	5.73e-05	0.00117	CcSEcCtD
Temozolomide—Infection—Ifosfamide—germ cell cancer	5.72e-05	0.00116	CcSEcCtD
Temozolomide—Tremor—Cisplatin—germ cell cancer	5.7e-05	0.00116	CcSEcCtD
Temozolomide—Alopecia—Etoposide—germ cell cancer	5.66e-05	0.00115	CcSEcCtD
Temozolomide—Nervous system disorder—Ifosfamide—germ cell cancer	5.65e-05	0.00115	CcSEcCtD
Temozolomide—Ill-defined disorder—Cisplatin—germ cell cancer	5.65e-05	0.00115	CcSEcCtD
Temozolomide—Thrombocytopenia—Ifosfamide—germ cell cancer	5.64e-05	0.00115	CcSEcCtD
Temozolomide—Anaemia—Cisplatin—germ cell cancer	5.62e-05	0.00114	CcSEcCtD
Temozolomide—Skin disorder—Ifosfamide—germ cell cancer	5.6e-05	0.00114	CcSEcCtD
Temozolomide—Hyperhidrosis—Ifosfamide—germ cell cancer	5.57e-05	0.00113	CcSEcCtD
Temozolomide—Feeling abnormal—Bleomycin—germ cell cancer	5.56e-05	0.00113	CcSEcCtD
Temozolomide—Anorexia—Ifosfamide—germ cell cancer	5.49e-05	0.00112	CcSEcCtD
Temozolomide—Malaise—Cisplatin—germ cell cancer	5.49e-05	0.00112	CcSEcCtD
Temozolomide—Decreased appetite—Dactinomycin—germ cell cancer	5.47e-05	0.00111	CcSEcCtD
Temozolomide—Diarrhoea—Vinblastine—germ cell cancer	5.46e-05	0.00111	CcSEcCtD
Temozolomide—Dysgeusia—Etoposide—germ cell cancer	5.46e-05	0.00111	CcSEcCtD
Temozolomide—Leukopenia—Cisplatin—germ cell cancer	5.45e-05	0.00111	CcSEcCtD
Temozolomide—Fatigue—Dactinomycin—germ cell cancer	5.42e-05	0.0011	CcSEcCtD
Temozolomide—Back pain—Etoposide—germ cell cancer	5.39e-05	0.0011	CcSEcCtD
Temozolomide—Pain—Dactinomycin—germ cell cancer	5.38e-05	0.00109	CcSEcCtD
Temozolomide—Urticaria—Bleomycin—germ cell cancer	5.36e-05	0.00109	CcSEcCtD
Temozolomide—Body temperature increased—Bleomycin—germ cell cancer	5.33e-05	0.00108	CcSEcCtD
Temozolomide—Dizziness—Vinblastine—germ cell cancer	5.28e-05	0.00107	CcSEcCtD
Temozolomide—Convulsion—Cisplatin—germ cell cancer	5.27e-05	0.00107	CcSEcCtD
Temozolomide—Mood swings—Methotrexate—germ cell cancer	5.25e-05	0.00107	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	5.25e-05	0.00107	CcSEcCtD
Temozolomide—Ataxia—Methotrexate—germ cell cancer	5.21e-05	0.00106	CcSEcCtD
Temozolomide—Myalgia—Cisplatin—germ cell cancer	5.18e-05	0.00105	CcSEcCtD
Temozolomide—Feeling abnormal—Dactinomycin—germ cell cancer	5.18e-05	0.00105	CcSEcCtD
Temozolomide—Paraesthesia—Ifosfamide—germ cell cancer	5.17e-05	0.00105	CcSEcCtD
Temozolomide—Ill-defined disorder—Etoposide—germ cell cancer	5.17e-05	0.00105	CcSEcCtD
Temozolomide—Anxiety—Cisplatin—germ cell cancer	5.16e-05	0.00105	CcSEcCtD
Temozolomide—Anaemia—Etoposide—germ cell cancer	5.15e-05	0.00105	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	5.15e-05	0.00105	CcSEcCtD
Temozolomide—Gastrointestinal pain—Dactinomycin—germ cell cancer	5.14e-05	0.00105	CcSEcCtD
Temozolomide—Dyspnoea—Ifosfamide—germ cell cancer	5.14e-05	0.00105	CcSEcCtD
Temozolomide—Somnolence—Ifosfamide—germ cell cancer	5.12e-05	0.00104	CcSEcCtD
Temozolomide—Discomfort—Cisplatin—germ cell cancer	5.12e-05	0.00104	CcSEcCtD
Temozolomide—Vomiting—Vinblastine—germ cell cancer	5.07e-05	0.00103	CcSEcCtD
Temozolomide—Malaise—Etoposide—germ cell cancer	5.03e-05	0.00102	CcSEcCtD
Temozolomide—Breast disorder—Methotrexate—germ cell cancer	5.01e-05	0.00102	CcSEcCtD
Temozolomide—Vertigo—Etoposide—germ cell cancer	5.01e-05	0.00102	CcSEcCtD
Temozolomide—Decreased appetite—Ifosfamide—germ cell cancer	5.01e-05	0.00102	CcSEcCtD
Temozolomide—Headache—Vinblastine—germ cell cancer	5e-05	0.00102	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	4.99e-05	0.00102	CcSEcCtD
Temozolomide—Leukopenia—Etoposide—germ cell cancer	4.99e-05	0.00102	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Body temperature increased—Dactinomycin—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Abdominal pain—Dactinomycin—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Fatigue—Ifosfamide—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Anaphylactic shock—Cisplatin—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Oedema—Cisplatin—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Hypersensitivity—Bleomycin—germ cell cancer	4.97e-05	0.00101	CcSEcCtD
Temozolomide—Infection—Cisplatin—germ cell cancer	4.93e-05	0.001	CcSEcCtD
Temozolomide—Pain—Ifosfamide—germ cell cancer	4.93e-05	0.001	CcSEcCtD
Temozolomide—Constipation—Ifosfamide—germ cell cancer	4.93e-05	0.001	CcSEcCtD
Temozolomide—Nervous system disorder—Cisplatin—germ cell cancer	4.87e-05	0.000991	CcSEcCtD
Temozolomide—Cough—Etoposide—germ cell cancer	4.87e-05	0.00099	CcSEcCtD
Temozolomide—Thrombocytopenia—Cisplatin—germ cell cancer	4.86e-05	0.00099	CcSEcCtD
Temozolomide—Asthenia—Bleomycin—germ cell cancer	4.84e-05	0.000984	CcSEcCtD
Temozolomide—Convulsion—Etoposide—germ cell cancer	4.83e-05	0.000983	CcSEcCtD
Temozolomide—Skin disorder—Cisplatin—germ cell cancer	4.82e-05	0.000982	CcSEcCtD
Temozolomide—Hypertension—Etoposide—germ cell cancer	4.81e-05	0.00098	CcSEcCtD
Temozolomide—Hyperhidrosis—Cisplatin—germ cell cancer	4.8e-05	0.000977	CcSEcCtD
Temozolomide—Pruritus—Bleomycin—germ cell cancer	4.77e-05	0.000971	CcSEcCtD
Temozolomide—Feeling abnormal—Ifosfamide—germ cell cancer	4.75e-05	0.000966	CcSEcCtD
Temozolomide—Nausea—Vinblastine—germ cell cancer	4.74e-05	0.000965	CcSEcCtD
Temozolomide—Anorexia—Cisplatin—germ cell cancer	4.73e-05	0.000964	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	4.71e-05	0.000959	CcSEcCtD
Temozolomide—Gastrointestinal pain—Ifosfamide—germ cell cancer	4.71e-05	0.000959	CcSEcCtD
Temozolomide—Discomfort—Etoposide—germ cell cancer	4.69e-05	0.000954	CcSEcCtD
Temozolomide—Hypersensitivity—Dactinomycin—germ cell cancer	4.63e-05	0.000943	CcSEcCtD
Temozolomide—Confusional state—Etoposide—germ cell cancer	4.59e-05	0.000934	CcSEcCtD
Temozolomide—Urticaria—Ifosfamide—germ cell cancer	4.58e-05	0.000931	CcSEcCtD
Temozolomide—Abdominal pain—Ifosfamide—germ cell cancer	4.55e-05	0.000927	CcSEcCtD
Temozolomide—Body temperature increased—Ifosfamide—germ cell cancer	4.55e-05	0.000927	CcSEcCtD
Temozolomide—Pancytopenia—Methotrexate—germ cell cancer	4.55e-05	0.000926	CcSEcCtD
Temozolomide—Anaphylactic shock—Etoposide—germ cell cancer	4.55e-05	0.000926	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	4.53e-05	0.000921	CcSEcCtD
Temozolomide—Infection—Etoposide—germ cell cancer	4.52e-05	0.00092	CcSEcCtD
Temozolomide—Asthenia—Dactinomycin—germ cell cancer	4.51e-05	0.000918	CcSEcCtD
Temozolomide—Neutropenia—Methotrexate—germ cell cancer	4.48e-05	0.000912	CcSEcCtD
Temozolomide—Dysuria—Methotrexate—germ cell cancer	4.48e-05	0.000912	CcSEcCtD
Temozolomide—Paraesthesia—Cisplatin—germ cell cancer	4.46e-05	0.000908	CcSEcCtD
Temozolomide—Thrombocytopenia—Etoposide—germ cell cancer	4.46e-05	0.000907	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Methotrexate—germ cell cancer	4.45e-05	0.000907	CcSEcCtD
Temozolomide—Dyspnoea—Cisplatin—germ cell cancer	4.43e-05	0.000901	CcSEcCtD
Temozolomide—Skin disorder—Etoposide—germ cell cancer	4.42e-05	0.0009	CcSEcCtD
Temozolomide—Erectile dysfunction—Methotrexate—germ cell cancer	4.41e-05	0.000898	CcSEcCtD
Temozolomide—Hyperhidrosis—Etoposide—germ cell cancer	4.4e-05	0.000895	CcSEcCtD
Temozolomide—Photosensitivity reaction—Methotrexate—germ cell cancer	4.37e-05	0.00089	CcSEcCtD
Temozolomide—Anorexia—Etoposide—germ cell cancer	4.34e-05	0.000883	CcSEcCtD
Temozolomide—Decreased appetite—Cisplatin—germ cell cancer	4.32e-05	0.000879	CcSEcCtD
Temozolomide—Diarrhoea—Dactinomycin—germ cell cancer	4.3e-05	0.000875	CcSEcCtD
Temozolomide—Pneumonia—Methotrexate—germ cell cancer	4.3e-05	0.000875	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Cisplatin—germ cell cancer	4.29e-05	0.000873	CcSEcCtD
Temozolomide—Vomiting—Bleomycin—germ cell cancer	4.29e-05	0.000872	CcSEcCtD
Temozolomide—Infestation NOS—Methotrexate—germ cell cancer	4.27e-05	0.00087	CcSEcCtD
Temozolomide—Infestation—Methotrexate—germ cell cancer	4.27e-05	0.00087	CcSEcCtD
Temozolomide—Depression—Methotrexate—germ cell cancer	4.26e-05	0.000867	CcSEcCtD
Temozolomide—Rash—Bleomycin—germ cell cancer	4.25e-05	0.000865	CcSEcCtD
Temozolomide—Pain—Cisplatin—germ cell cancer	4.25e-05	0.000864	CcSEcCtD
Temozolomide—Dermatitis—Bleomycin—germ cell cancer	4.25e-05	0.000864	CcSEcCtD
Temozolomide—Hypersensitivity—Ifosfamide—germ cell cancer	4.24e-05	0.000864	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	4.24e-05	0.000862	CcSEcCtD
Temozolomide—Stomatitis—Methotrexate—germ cell cancer	4.17e-05	0.000848	CcSEcCtD
Temozolomide—Asthenia—Ifosfamide—germ cell cancer	4.13e-05	0.000841	CcSEcCtD
Temozolomide—Feeling abnormal—Cisplatin—germ cell cancer	4.09e-05	0.000833	CcSEcCtD
Temozolomide—Paraesthesia—Etoposide—germ cell cancer	4.09e-05	0.000832	CcSEcCtD
Temozolomide—Pruritus—Ifosfamide—germ cell cancer	4.08e-05	0.00083	CcSEcCtD
Temozolomide—Dyspnoea—Etoposide—germ cell cancer	4.06e-05	0.000826	CcSEcCtD
Temozolomide—Somnolence—Etoposide—germ cell cancer	4.05e-05	0.000823	CcSEcCtD
Temozolomide—Hepatobiliary disease—Methotrexate—germ cell cancer	4.04e-05	0.000823	CcSEcCtD
Temozolomide—Nausea—Bleomycin—germ cell cancer	4e-05	0.000815	CcSEcCtD
Temozolomide—Vomiting—Dactinomycin—germ cell cancer	4e-05	0.000814	CcSEcCtD
Temozolomide—Rash—Dactinomycin—germ cell cancer	3.96e-05	0.000807	CcSEcCtD
Temozolomide—Decreased appetite—Etoposide—germ cell cancer	3.96e-05	0.000805	CcSEcCtD
Temozolomide—Diarrhoea—Ifosfamide—germ cell cancer	3.94e-05	0.000802	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Etoposide—germ cell cancer	3.93e-05	0.0008	CcSEcCtD
Temozolomide—Body temperature increased—Cisplatin—germ cell cancer	3.93e-05	0.000799	CcSEcCtD
Temozolomide—Fatigue—Etoposide—germ cell cancer	3.92e-05	0.000798	CcSEcCtD
Temozolomide—Constipation—Etoposide—germ cell cancer	3.89e-05	0.000792	CcSEcCtD
Temozolomide—Pain—Etoposide—germ cell cancer	3.89e-05	0.000792	CcSEcCtD
Temozolomide—Haemoglobin—Methotrexate—germ cell cancer	3.86e-05	0.000785	CcSEcCtD
Temozolomide—Haemorrhage—Methotrexate—germ cell cancer	3.84e-05	0.000781	CcSEcCtD
Temozolomide—Hepatitis—Methotrexate—germ cell cancer	3.84e-05	0.000781	CcSEcCtD
Temozolomide—Dizziness—Ifosfamide—germ cell cancer	3.81e-05	0.000775	CcSEcCtD
Temozolomide—Pharyngitis—Methotrexate—germ cell cancer	3.81e-05	0.000775	CcSEcCtD
Temozolomide—Urinary tract disorder—Methotrexate—germ cell cancer	3.79e-05	0.000771	CcSEcCtD
Temozolomide—Urethral disorder—Methotrexate—germ cell cancer	3.76e-05	0.000765	CcSEcCtD
Temozolomide—Feeling abnormal—Etoposide—germ cell cancer	3.75e-05	0.000763	CcSEcCtD
Temozolomide—Nausea—Dactinomycin—germ cell cancer	3.73e-05	0.00076	CcSEcCtD
Temozolomide—Gastrointestinal pain—Etoposide—germ cell cancer	3.72e-05	0.000757	CcSEcCtD
Temozolomide—Visual impairment—Methotrexate—germ cell cancer	3.7e-05	0.000752	CcSEcCtD
Temozolomide—Vomiting—Ifosfamide—germ cell cancer	3.66e-05	0.000746	CcSEcCtD
Temozolomide—Hypersensitivity—Cisplatin—germ cell cancer	3.66e-05	0.000745	CcSEcCtD
Temozolomide—Rash—Ifosfamide—germ cell cancer	3.63e-05	0.000739	CcSEcCtD
Temozolomide—Dermatitis—Ifosfamide—germ cell cancer	3.63e-05	0.000739	CcSEcCtD
Temozolomide—Erythema multiforme—Methotrexate—germ cell cancer	3.63e-05	0.000738	CcSEcCtD
Temozolomide—Urticaria—Etoposide—germ cell cancer	3.61e-05	0.000736	CcSEcCtD
Temozolomide—Abdominal pain—Etoposide—germ cell cancer	3.6e-05	0.000732	CcSEcCtD
Temozolomide—Body temperature increased—Etoposide—germ cell cancer	3.6e-05	0.000732	CcSEcCtD
Temozolomide—Eye disorder—Methotrexate—germ cell cancer	3.59e-05	0.00073	CcSEcCtD
Temozolomide—Tinnitus—Methotrexate—germ cell cancer	3.58e-05	0.000728	CcSEcCtD
Temozolomide—Asthenia—Cisplatin—germ cell cancer	3.56e-05	0.000725	CcSEcCtD
Temozolomide—Cardiac disorder—Methotrexate—germ cell cancer	3.56e-05	0.000725	CcSEcCtD
Temozolomide—Angiopathy—Methotrexate—germ cell cancer	3.48e-05	0.000708	CcSEcCtD
Temozolomide—Immune system disorder—Methotrexate—germ cell cancer	3.47e-05	0.000705	CcSEcCtD
Temozolomide—Mediastinal disorder—Methotrexate—germ cell cancer	3.46e-05	0.000704	CcSEcCtD
Temozolomide—Chills—Methotrexate—germ cell cancer	3.44e-05	0.000701	CcSEcCtD
Temozolomide—Nausea—Ifosfamide—germ cell cancer	3.42e-05	0.000696	CcSEcCtD
Temozolomide—Diarrhoea—Cisplatin—germ cell cancer	3.4e-05	0.000692	CcSEcCtD
Temozolomide—Alopecia—Methotrexate—germ cell cancer	3.39e-05	0.00069	CcSEcCtD
Temozolomide—Mental disorder—Methotrexate—germ cell cancer	3.36e-05	0.000684	CcSEcCtD
Temozolomide—Hypersensitivity—Etoposide—germ cell cancer	3.35e-05	0.000682	CcSEcCtD
Temozolomide—Erythema—Methotrexate—germ cell cancer	3.34e-05	0.00068	CcSEcCtD
Temozolomide—Malnutrition—Methotrexate—germ cell cancer	3.34e-05	0.00068	CcSEcCtD
Temozolomide—Dysgeusia—Methotrexate—germ cell cancer	3.27e-05	0.000666	CcSEcCtD
Temozolomide—Asthenia—Etoposide—germ cell cancer	3.26e-05	0.000664	CcSEcCtD
Temozolomide—Back pain—Methotrexate—germ cell cancer	3.23e-05	0.000657	CcSEcCtD
Temozolomide—Pruritus—Etoposide—germ cell cancer	3.22e-05	0.000655	CcSEcCtD
Temozolomide—Vomiting—Cisplatin—germ cell cancer	3.16e-05	0.000643	CcSEcCtD
Temozolomide—Vision blurred—Methotrexate—germ cell cancer	3.15e-05	0.000641	CcSEcCtD
Temozolomide—Rash—Cisplatin—germ cell cancer	3.13e-05	0.000637	CcSEcCtD
Temozolomide—Dermatitis—Cisplatin—germ cell cancer	3.13e-05	0.000637	CcSEcCtD
Temozolomide—Diarrhoea—Etoposide—germ cell cancer	3.11e-05	0.000634	CcSEcCtD
Temozolomide—Ill-defined disorder—Methotrexate—germ cell cancer	3.1e-05	0.000631	CcSEcCtD
Temozolomide—Anaemia—Methotrexate—germ cell cancer	3.09e-05	0.000628	CcSEcCtD
Temozolomide—Malaise—Methotrexate—germ cell cancer	3.01e-05	0.000613	CcSEcCtD
Temozolomide—Dizziness—Etoposide—germ cell cancer	3.01e-05	0.000612	CcSEcCtD
Temozolomide—Vertigo—Methotrexate—germ cell cancer	3e-05	0.000611	CcSEcCtD
Temozolomide—Leukopenia—Methotrexate—germ cell cancer	2.99e-05	0.000608	CcSEcCtD
Temozolomide—Nausea—Cisplatin—germ cell cancer	2.95e-05	0.0006	CcSEcCtD
Temozolomide—Cough—Methotrexate—germ cell cancer	2.91e-05	0.000593	CcSEcCtD
Temozolomide—Convulsion—Methotrexate—germ cell cancer	2.89e-05	0.000589	CcSEcCtD
Temozolomide—Vomiting—Etoposide—germ cell cancer	2.89e-05	0.000589	CcSEcCtD
Temozolomide—Rash—Etoposide—germ cell cancer	2.87e-05	0.000584	CcSEcCtD
Temozolomide—Dermatitis—Etoposide—germ cell cancer	2.87e-05	0.000583	CcSEcCtD
Temozolomide—Headache—Etoposide—germ cell cancer	2.85e-05	0.00058	CcSEcCtD
Temozolomide—Myalgia—Methotrexate—germ cell cancer	2.84e-05	0.000579	CcSEcCtD
Temozolomide—Arthralgia—Methotrexate—germ cell cancer	2.84e-05	0.000579	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	2.82e-05	0.000575	CcSEcCtD
Temozolomide—Discomfort—Methotrexate—germ cell cancer	2.81e-05	0.000572	CcSEcCtD
Temozolomide—Confusional state—Methotrexate—germ cell cancer	2.75e-05	0.000559	CcSEcCtD
Temozolomide—Anaphylactic shock—Methotrexate—germ cell cancer	2.73e-05	0.000555	CcSEcCtD
Temozolomide—Infection—Methotrexate—germ cell cancer	2.71e-05	0.000551	CcSEcCtD
Temozolomide—Nausea—Etoposide—germ cell cancer	2.7e-05	0.00055	CcSEcCtD
Temozolomide—Nervous system disorder—Methotrexate—germ cell cancer	2.67e-05	0.000544	CcSEcCtD
Temozolomide—Thrombocytopenia—Methotrexate—germ cell cancer	2.67e-05	0.000543	CcSEcCtD
Temozolomide—Skin disorder—Methotrexate—germ cell cancer	2.65e-05	0.000539	CcSEcCtD
Temozolomide—Hyperhidrosis—Methotrexate—germ cell cancer	2.63e-05	0.000536	CcSEcCtD
Temozolomide—Anorexia—Methotrexate—germ cell cancer	2.6e-05	0.000529	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	2.48e-05	0.000505	CcSEcCtD
Temozolomide—Insomnia—Methotrexate—germ cell cancer	2.47e-05	0.000502	CcSEcCtD
Temozolomide—Paraesthesia—Methotrexate—germ cell cancer	2.45e-05	0.000498	CcSEcCtD
Temozolomide—Dyspnoea—Methotrexate—germ cell cancer	2.43e-05	0.000495	CcSEcCtD
Temozolomide—Somnolence—Methotrexate—germ cell cancer	2.42e-05	0.000493	CcSEcCtD
Temozolomide—Dyspepsia—Methotrexate—germ cell cancer	2.4e-05	0.000488	CcSEcCtD
Temozolomide—Decreased appetite—Methotrexate—germ cell cancer	2.37e-05	0.000482	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Methotrexate—germ cell cancer	2.35e-05	0.000479	CcSEcCtD
Temozolomide—Fatigue—Methotrexate—germ cell cancer	2.35e-05	0.000478	CcSEcCtD
Temozolomide—Pain—Methotrexate—germ cell cancer	2.33e-05	0.000474	CcSEcCtD
Temozolomide—Feeling abnormal—Methotrexate—germ cell cancer	2.25e-05	0.000457	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methotrexate—germ cell cancer	2.23e-05	0.000454	CcSEcCtD
Temozolomide—Urticaria—Methotrexate—germ cell cancer	2.17e-05	0.000441	CcSEcCtD
Temozolomide—Abdominal pain—Methotrexate—germ cell cancer	2.15e-05	0.000439	CcSEcCtD
Temozolomide—Body temperature increased—Methotrexate—germ cell cancer	2.15e-05	0.000439	CcSEcCtD
Temozolomide—Hypersensitivity—Methotrexate—germ cell cancer	2.01e-05	0.000409	CcSEcCtD
Temozolomide—Asthenia—Methotrexate—germ cell cancer	1.96e-05	0.000398	CcSEcCtD
Temozolomide—Pruritus—Methotrexate—germ cell cancer	1.93e-05	0.000392	CcSEcCtD
Temozolomide—Diarrhoea—Methotrexate—germ cell cancer	1.86e-05	0.00038	CcSEcCtD
Temozolomide—Dizziness—Methotrexate—germ cell cancer	1.8e-05	0.000367	CcSEcCtD
Temozolomide—Vomiting—Methotrexate—germ cell cancer	1.73e-05	0.000353	CcSEcCtD
Temozolomide—Rash—Methotrexate—germ cell cancer	1.72e-05	0.00035	CcSEcCtD
Temozolomide—Dermatitis—Methotrexate—germ cell cancer	1.72e-05	0.000349	CcSEcCtD
Temozolomide—Headache—Methotrexate—germ cell cancer	1.71e-05	0.000348	CcSEcCtD
Temozolomide—Nausea—Methotrexate—germ cell cancer	1.62e-05	0.000329	CcSEcCtD
